Back to browse

Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by promoting endogenous MBNL1 expression

Paper ID

PAPER000189

Year

2023

DOI

10.1016/j.omtn.2023.09.001

PMID

37744174

Journal

Molecular Therapy Nucleic Acids

Source URL

Experiments

• EXP001027 with Pip9b2 (PMO (antimiR))
• EXP001028 with Pip9b2 (PMO (antimiR))
• EXP001029 with Pip9b2KC (PMO (antimiR))
• EXP001030 with Pip9b2KC (PMO (antimiR))
• EXP001031 with Pip6aKC (PMO (antimiR))
• EXP001032 with Pip6aKC (PMO (antimiR))
• EXP001033 with Pip9b2 (PMO (antimiR))
• EXP001034 with Pip9b2 (PMO (antimiR))
• EXP001035 with Pip9b2KC (PMO (antimiR))
• EXP001036 with Pip9b2KC (PMO (antimiR))
• EXP001037 with Pip6aKC (PMO (antimiR))
• EXP001038 with Pip6aKC (PMO (antimiR))
• EXP001039 with Pip9b2 (PMO (antimiR))
• EXP001040 with Pip9b2 (PMO (antimiR))